UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000029982
Receipt No. R000034244
Scientific Title A Retrospective Study of Safety and Efficacy for Re-treatment of Brentuximab-Vedotin (BV) in Patients With Relapsed/Refractory (R/R) classical Hodgkin Lymphoma (cHL)/ systemic Anaplastic Large-cell Lymphoma (sALCL)
Date of disclosure of the study information 2017/11/15
Last modified on 2019/09/02 19:15:29

No. Disposal Last modified on Item of update
1 Insert 2017/11/15 13:51:46
2 Update 2017/11/15 13:56:00 Organization1
Address1
Tel1
3 Update 2018/01/10 12:42:54 Recruitment status
4 Update 2018/08/03 12:12:07 Recruitment status
Last follow-up date
Date of closure to data entry
5 Update 2019/09/02 18:57:48 Recruitment status
Date of IRB
Date trial data considered complete
Date analysis concluded
6 Update 2019/09/02 19:12:45 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
7 Update 2019/09/02 19:15:29 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address


Zip code
Address
Organization
Organization
Address
Address
Tel
Email


Contact us.